EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation

Paolo Lazzari, Marco Spiga, Monica Sani, Matteo Zanda, Ian N Fleming

Hypoxia · 2017

DOI: 10.2147/hp.s132832 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hypoxia, 2017. Verfasst von Paolo Lazzari und 4 weiteren Autor:innen. Beteiligte Einrichtung: KemoTech s.r.l., Parco Scientifico della Sardegna, Pula, Cagliari. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

anti-mitoticbreast cancercell deathhypoxiareductasetubulysin

Autor:innen und Institutionen

  • KemoTech s.r.l., Parco Scientifico della Sardegna, Pula, Cagliari.
  • C.N.R. - Istituto di Chimica del Riconoscimento Molecolare, Sezione 'A. Quilico', Milano, Italy.
  • Kosterlitz Centre for Therapeutics, Institute of Medical Sciences, University of Aberdeen.
  • Aberdeen Biomedical Imaging Centre, Institute of Medical Sciences, Foresterhill, Aberdeen, Scotland, UK.

Zitieren

APA

Lazzari, P., Spiga, M., Sani, M., Zanda, M., & Fleming, I. N. (2017). KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation. Hypoxia. https://doi.org/10.2147/hp.s132832

Vancouver

Lazzari P, Spiga M, Sani M, Zanda M, Fleming IN. KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation. Hypoxia. 2017. doi:10.2147/hp.s132832

BibTeX
@article{Lazzari2017,
  author = {Lazzari, Paolo and Spiga, Marco and Sani, Monica and Zanda, Matteo and Fleming, Ian N},
  title = {KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation},
  journal = {Hypoxia},
  year = {2017},
  doi = {10.2147/hp.s132832}
}
Kostenlos starten →